DV
Therapeutic Areas
Edulis Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EDLS-201 | Inflammatory Bowel Disease (Crohn's Disease) | Preclinical |
| EDLS-302 | Microbiome Modulation | Discovery |
| EDLS-401 | Weight Loss | Discovery |
| Endoscopic Accessory Platform | Platform Product (Device) | Prototyping |
Leadership Team at Edulis Therapeutics
SM
Spencer Matonis
Founder & CEO
DC
Dr. Christopher Bettinger
Scientific Advisor
DJ
Dr. Juan Genere
Clinical Partner